Cathie Wood says her firm is testing a more aggressive strategy that would be ‘ARK on steroids’

Cathie Wood — known for her innovation ETFs that garnered billions in inflows during the pandemic — said Ark Invest is internally testing a fund that takes the strategy a step further by simultaneously betting against major stocks in the benchmarks that are being disrupted.

We are primarily funded by readers. Please subscribe and donate to support us!

“We think the benchmarks are where the big risks are long-term because they are filling up with value-traps, those companies that have done very well historically but are going to be disintermediated and disrupted by the massive amount of innovation that’s taking place,” Wood added.

Looks like Cathie Wood had found another way to attract investors money. People buying on these ark funds need to understand that the stocks inside are very random. Investors might easily lose money since many of them do not even realize what are they buying and investing.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.